" class="no-js "lang="en-US"> Haemonetics Corporation Archives - Medtech Alert
Thursday, February 09, 2023

Sort by:

Date

Top Post

CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM

CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]

Haemonetics Appoints James D'Arecca Chief Financial Officer

Haemonetics Corporation (NYSE: HAE) today announced that James C. D’Arecca will join the Company as Executive […]

Haemonetics Announces VASCADE MVP® Venous Vascular Closure System Gains the First and Only FDA Approval for Same-Day Discharge Following Atrial Fibrillation Ablation

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to […]

  1. Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board Read more
  2. Toragen Announces Appointment of Chief Scientific Officer Read more
  3. First Citizens Bank Provides $31.2 Million for Acquisition of Cancer Treatment Center in Columbia, South Carolina Read more
  4. Roche Expands Collaboration with Janssen to Advance Personalised Healthcare Through Companion Diagnostics Read more
  5. ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Read more